Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Assets (2016 - 2025)

Haemonetics has reported Return on Assets over the past 16 years, most recently at 0.07% for Q4 2025.

  • Quarterly results put Return on Assets at 0.07% for Q4 2025, up 2.0% from a year ago — trailing twelve months through Dec 2025 was 0.07% (up 2.0% YoY), and the annual figure for FY2025 was 0.07%, up 2.0%.
  • Return on Assets for Q4 2025 was 0.07% at Haemonetics, up from 0.07% in the prior quarter.
  • Over the last five years, Return on Assets for HAE hit a ceiling of 0.07% in Q4 2025 and a floor of 0.01% in Q1 2022.
  • Median Return on Assets over the past 5 years was 0.05% (2022), compared with a mean of 0.05%.
  • Peak annual rise in Return on Assets hit 4bps in 2022, while the deepest fall reached -7bps in 2022.
  • Haemonetics' Return on Assets stood at 0.02% in 2021, then soared by 195bps to 0.05% in 2022, then grew by 18bps to 0.06% in 2023, then fell by -14bps to 0.05% in 2024, then skyrocketed by 38bps to 0.07% in 2025.
  • The last three reported values for Return on Assets were 0.07% (Q4 2025), 0.07% (Q3 2025), and 0.07% (Q2 2025) per Business Quant data.